INTRODUCTION
Hyperparathyroidism is a disease characterized by inap pro priately elevated parathyroid hormone (PTH) levels. Prevalence for hyperparathyroidism is around 0.3% in the general po pu lation [1] . Primary hyperparathyroidism is a condition charac terized by inappropriate excess secretion of PTH leading to hypercalcemia and hypophosphatemia. The majority of primary Purpose: Patients with secondary hyperparathyroidism are at high risk for developing postoperative hypocalcemia. However, there are limited data regarding predictors of postoperative hypocalcemia in renal failure patient with secondary hyperparathyroidism. This study aimed to determine the clinical presentations of renal hyperparathyroidism and the predictors of early postoperative hypocalcemia after total parathyroidectomy. Methods: Data of patients with renal hyperparathyroidism who underwent total parathyroidectomy between January 2007 to December 2014 were reviewed retrospectively. Patients were divided into 2 cohort groups according to their serum calcium levels within 24 hours of parathyroidectomy: the hypocalcemia group (calcium levels of 2 mmol/L or less), and the normocalcemia group (calcium levels more than 2 mmol/L). With the use of multivariable logistic regression analyses, the predictors of early postoperative hypocalcemia after total parathyroidectomy in patients with renal hyperparathyroidism were investigated. Results: Among 68 patients, 56 patients (82.4%) were symptomatic preoperatively. Fifty patients (73.5%) presented with bone pain and 14 patients (20.6%) had muscle weakness. Early postoperative hypocalcemia occurred in 25 patients (36.8%). Preoperative alkaline phosphatase level was the predictor of early postoperative hypocalcemia (adjusted odds ratio, 1.004; 95% confidence interval, 1.001-1.006; P = 0.002). Conclusion: Results from our study show that most of the patients with renal hyperparathyroidism were symptomatic preoperatively and the most common clinical presentations were bone pain and muscle weakness. The significant predictor of early postoperative hypocalcemia after total parathyroidectomy was the preoperative alkaline phosphatase levels.
[Ann Surg Treat Res 2020;98(1): [1] [2] [3] [4] [5] [6] hyperparathyroidism is caused by autonomous PTH secretion from a solitary parathyroid adenoma.
Secondary hyperparathyroidism (SHPT) refers to excessive secretion of PTH in response to hypocalcemia and associated hyperplasia of the parathyroid glands. SHPT enhances vas cular calcification with increased cardiovascular mortality. Chronic renal failure, hypermagnesemia, osteoporosis and osteomalacia/rickets can cause SHPT. By far, the most common cause of SHPT is a chronic renal failure, though its clinical effects were not well elucidated until recently. Pathogenesis of SHPT is complicated, every aspect of renal failure from decrea sed synthesis function to metabolic abnormalities to even treatment of renal failure contribute to it [2] . Factors that lead to hypertrophy and hyperplasia transformation of the parathyroid gland with subsequent elevation of PTH in order to normalize serum calcium level such as hyperphosphataemia and hypo calcemia, reduce renal 1alphahydroxylase and calcitriol, bony resistance to PTH (if excessive PTH), change in PTH set point (rise in set point), and aluminium intoxication.
Initial treatment for SHPT is aimed to bring the serum cal cium and phosphate to a physiological level to prevent over sti mu lation of parathyroid glands and hence over production of PTH. Medical therapy includes calcium supplement, vitamin D supplement, phosphatepoor diets, aluminumbinding agents, hemodialysis with calciumenriched dialysate and cal ci mimetic agent, Cinacalcet [2] . Despite the advent of new thera peutic agents, the rate of parathyroidectomy did not change significantly over the past 20 years. Parathyroidectomy is indicated in patients who failed medical treatment [3, 4] , pa tients with intractable bone pain/pruritus, fracture, and patients with symptomatic ectopic calcification [5] .
Hypocalcemia or even hungry bone syndrome is a well known and severe complication after parathyroidectomy [6 8 ], but not all patient develop this complication. Thus, it would be beneficial and clinically significant to identify the highrisk patient group that develops postoperative hypocalcemia/hungry bone syndrome in order to monitor them more closely during the postoperative period. This study was designed to determine the clinical presentations of renal hyperparathyroidism and the predictors of early postoperative hypocalcemia after total parathyroidectomy.
METHODS

Study design and setting
This is a retrospective review of patients who underwent total parathyroidectomy for SHPT over 8 years from January 2007 to December 2014 in Hospital Raja Perempuan Zainab II (HRPZ II), Malaysia.
Ethical approval
The Universiti Sains Malaysia (USM) and Ministry of Health (MOH), Malaysia Institutional Review Board (approval number: USM/JEPeM/16020065 and NMRR1625029616) approved this study.
Participants
There were 88 patients with SHPT who underwent parathy roidectomy retrieved from the records of the operation theater in HRPZ II from January 1st, 2007 to December 31st, 2014. Sixty eight patients met the eligibility criteria.
The inclusion criteria for this study included renal failure pa tients with SHPT who underwent total parathyroi dectomy du ring the study period. Patients with renal hyperparathy roidism who underwent parathyroidectomy with incomplete data or missing data and aged below 16 years old were excluded.
Sample size estimation
The sample size was calculated using 2 means and 2 propor tions formula for both continuous and categorical variables, res pec tively, to obtain the appropriate sample size for the pre dictors of early postoperative hypocalcemia after total para thyroidectomy in renal failure patients with SHPT. The cal culation was done using the PS: Power and Sample Size Cal culation Version 3.0.12 (DalePlummer, Nashvile, TN, USA). The final targeted sample size was determined by considering a 20% dropout rate. The estimated sample size for this study was 56 samples.
Data collection
This study involved secondary data collection. The list of patients with SHPT who underwent parathyroidectomy in HRPZ II during the 8 years from the 1st of January 2007 until the 31st of December 2014 was obtained from the records of the operation theater.
In HRPZ II, initial bilateral neck exploration and total para thyroidectomy without autotransplantation were performed for all patients who required surgical intervention since the renal transplantation rate is low in Malaysia and the ma jority of patients require longterm hemodialysis after para thyroidectomy, and consequently the risk of recurrence is high and not negligible.
Patients' medical records were reviewed in detail to obtain the clinical data and biochemical parameters. All information needed is recorded in the data collection form to reduce bias. Variables that were required for the study were age, gender, duration of dialysis, main complaint, occurrence of renal hyper para thyroidism, preoperative blood investigation (serum calcium, albumin, phosphate, ALP, intact PTH [iPTH], and creatinine levels), postoperative calcium levels (within 24 hours of total parathyroidectomy before calcium infusion was started), and glands histopathological results.
Patients were divided into 2 groups based on the post operative calcium levels within 24 hours: normocalcemia (calcium levels more than 2 mmol/L) and hypocalcemia (calcium levels 2 mmol/L or <2 mmol/L) group [6, 9] .
Statistical analysis
The data were analysed by univariable analysis (simple logis tic regression) and multivariable analysis (multiple logistic re gres sion). Early postoperative hypocalcemia after total para thyroidectomy was the outcome variable. Independent variables were possible predictors of early postoperative hypo calcemia after total parathyroidectomy included age, sex, clinical presentation (symptomatic or asymptomatic), duration of hemodialysis, preoperative levels of calcium, albumin, phos phate, ALP, iPTH, and creatinine. In univariable analysis, the aim was to screen for important independent variables with a Pvalue less than 0.25 (P < 0.25) and clinically significant variables [10] . multivariable analysis was used to run all variables from univariable analysis at one time.
In this study, several variables with P < 0.25 or clinically im por tant such as age, preoperative levels of calcium, phosphate, ALP, iPTH, and creatinine were selected as continuous variables for multiple logistic regression based on the principle of parsimony, the best fit, biologically plausible, and statistically significant. Statistical analysis was carried out using IBM SPSS Statistics ver. 22 .0 (IBM Co., Armonk, NY, USA). The limit of significance was set at 0.05.
RESULTS
Patient demographics and clinical profiles
Among 88 patients with SHPT who underwent parathyroi dectomy reviewed from the medical records, 68 patients met the inclusion and exclusion criteria and were included in the study. Twenty patients were excluded due to surgery for primary hyperparathyroidism (n = 10), incomplete data or missing data (n = 6), reexploration after primary surgery (n = 3), and aged less than 16 years old (n = 1). Table 1 shows the characteristics of patients with renal hyperparathyroidism. In total, 47 males and 21 females were included in the study with an average age of 42.9 years old (standard deviation, 12.21). Among the 68 patients, 56 patients (82.4%) were symptomatic preoperatively. Patients presented with different symptoms or a combination of symptoms. Fifty patients (73.5%) presented with bone pain and 14 patients (20.6%) had muscle weakness. Early postoperative hypocalcemia occurred in 25 patients (36.8%). Table 2 shows univariable analyses on the predictors of early postoperative hypocalcemia after total parathyroidectomy in patients with renal hyperparathyroidism. Using simple logistic regression, age (crude odds ratio [OR], 0.957; 95% confidence interval [CI], 0.916-0.999; P = 0.043) and preoperative levels of ALP (crude OR, 1.004; 95% CI, 1.001-1.006; P = 0.002) were seen to be significant with a Pvalue less than 0.05. Simple logistic regression analyses showed that patients in the hypocalcemia Values are presented as mean (range) or number (%). Patients were divided into 2 groups based on the postoperative calcium levels within 24 hours: normocalcemia (calcium levels more than 2 mmol/L) and hypocalcemia (calcium levels 2 mmol/ L or <2 mmol/L) group. a) Some patients had more than one preoperative symptom. b) Post operative serum calcium level within 24 hours of total para thy roi dectomy before calcium infusion was started.
Predictors of early postoperative hypocalcemia after total parathyroidectomy in renal hyperparathyroidism
group were significantly younger than normocalcemia group (38.9 years vs. 45.2 years). Preoperative level of ALP was significantly higher in hypocalcemia group (603 IU/L vs. 283 IU/ L). In this dataset, age, preoperative levels of calcium, phosphate, ALP, iPTH, and creatinine were included as continuous variables in the multiple logistic regression based on 4 principles of the best fit, parsimonious, statistically significant, and clinically meaningful.
Multiple logistic regression showed that the preoperative ALP level was the predictor of early postoperative hypocalcemia after total parathyroidectomy in patients with renal hyper parathyroidism. After adjustment for age, preoperative levels of calcium, phosphate, iPTH, and creatinine, the results showed that higher preoperative ALP level resulted in greater odds of getting postoperative hypocalcemia (adjusted OR, 1.004; 95% CI, 1.001-1.006; P = 0.002).
DISCUSSION
The present study explored the clinical presentations of renal hyperparathyroidism and the predictors of early post operative hypocalcemia after total parathyroidectomy. The clinical effects of renal hyperparathyroidism include refractory pruritus, bone or joints pain, muscular weakness, progressive soft tissue calcification, renal stone, constipation, peptic ulcer disease, spontaneous long bone fracture and even psychosis or dementia [9] . From this study, bone pain was observed as the most common clinical presentation followed by muscular weakness, paraesthesia, headache/dizziness, renal stone, nausea and vomiting, peptic ulcer, and psychosis/dementia. None of the patients suffered from a spontaneous long bone fracture.
Postoperative hypocalcemia is a wellknown and severe complication after parathyroidectomy [7, 8, 11] . The incidence of postoperative hypocalcemia among patients with primary hyperparathyroidism who underwent parathyroidectomy has been reported to be 10% to 46%, and among patient with SHPT has been reported to be up to 26% to 95% [6, 7] . This study has established that the proportion of postoperative hypocalcemia among the study subjects was 36.8%, and the results are comparable to other published studies [6, 7] . The pathogenesis of postoperative hypocalcemia is multifactorial and its pri mary mechanism is possible due to abrupt removal of PTH stimulation after parathyroidectomy; hence, excess osteoclastic activity stops, but osteoblastic activity continues causing excess calcium and phosphate to pass into bones [12] .
Many prior studies have evaluated the predictors of post operative hypocalcemia in patients with primary hyper para thyroidism; however, the study of predictors of postoperative hypocalcemia in SHPT in renal failure patients is still limited [1215] . Few studies have attempted to identify predictors for early postoperative hypocalcemia in SHPT with mixed results. Previous studies have identified several predictors for the occurrence of early postoperative hypocalcemia after parathyroidectomy, which included the age of patients, pre operative levels of calcium, alkaline phosphatase, and albumin and weight of the parathyroid gland [2, 6, 9, 16] . A study by Hamouda et al. [6] involved 76 patients in Saudi Arabia aimed to identify the risk factors for developing early postoperative hypocalcemia after parathyroidectomy for SHPT has concluded that age, level of preoperative calcium, ALP, and serum albumin correlated with early postoperative hypocalcemia.
ALP level elevates due to increased osteoblastic activity in hyperparathyroidism patients secondary to stimulation from the high PTH level and is related to the degree of bone disease [17, 18] . Patients with higher preoperative ALP are more prone to develop postoperative hypocalcemia or even hungry bone syndrome [2, 6, 9, 19 ]. A regional study involving 2 tertiary institutions (Tan Tock Seng Hospital Singapore and Kuala Lumpur General Hospital) reported a strong relationship between ALP and postoperative hypocalcemia in patients with primary hyperparathyroidism [13] . The study concluded that patients with preoperative ALP less than 340 IU/L are unlikely to develop symptomatic postoperative hypocalcemia (100% sensitivity, 95% specificity) and also recommended preoperative ALP to be used to complement clinical protocol for postoperative hypocalcemia management in parathyroidectomy patients [13] .
Patient with SHPT develops more profound postoperative hypocalcemia. As such, preoperative predictors of hypocalcemia are particularly crucial for postoperative management [9] . The present study revealed that patients in the hypocalcemia group presented with a higher mean of preoperative ALP level compared with the normocalcemia group (603 IU/L vs. 283 IU/ L, respectively). Using multiple logistic regression analysis, high preoperative ALP exhibited positive predictive values of development of early postoperative hypocalcemia with an adjusted odds ratio of 1.004. Patients with high preoperative ALP are highly recommended to be monitored more closely in the early postoperative period, preferably in the high dependency unit, along with more frequent serum calcium monitoring to avoid the complication of early postoperative hypocalcemia.
Postoperative empirical intravenous calcium supplementation should be given in the immediate postoperative period and at a higher dose for the highrisk group. When oral intake is feasible, oral vitamin D and calcium supplement should be started [20] . By implementing this protocol, severe hypocalcemia can be avoided and an uneventful postoperative period can be secured. Age had been identified as one of the predictors for postoperative hypocalcemia in patients with primary hyperparathyroidism going back to the year 1988 [21] . Advanced age was associated with postoperative hypocalcemia in primary hyperparathyroidism and a few recent studies suggested that elderly patients usually have vitamin D deficiency and more inadequate oral intake: therefore, aging was associated with an increased risk of postoperative hypocalcemia [19, 22] . In con trast, studies by Torer et al. [9] and Hamouda et al. [6] involving only SHPT patients found that younger age group patients are more prone to develop postoperative hypocalcemia after total parathyroidectomy. The present study on patients with SHPT, however, showed no association between age and postoperative hypocalcemia. The mean age for hypocalcemia group was lower (38.9 years vs. 45.2 years) and univariable analysis showed a significant association but not significant in subsequent multiple logistic regression analysis.
Preoperative PTH level is related to the severity of renal osteodystrophy. Therefore, a positive association between the increased level of preoperative serum PTH with postoperative hypocalcemia is expected. Patients in hypocalcemia group showed a higher level of the preoperative PTH than the normo calcemia group (729.51 pg/mL vs. 548.50 pg/mL). However, the difference was not statistically significant. Similarly, some studies also found that there was no association between preoperative PTH and early postoperative hypocalcemia [6, 7, 9, 2325] .
Ellul et al. [23] conducted a study to analyze the predictive value of preoperative serum phosphate level as an indicator for developing postoperative hypocalcemia and found that there was no significant association between the preoperative phosphate level and postoperative hypocalcemia following total parathyroidectomy. The difference was not significant on multivariable analysis in the present study.
None of the other factors evaluated including gender, dura tion of hemodialysis, duration of renal failure, serum calcium, serum albumin, and creatinine levels were predictive of the development of postoperative hypocalcemia in the renal patients with SHPT after total parathyroidectomy.
There were some limitations found in this study. This study carries the usual limitation of a retrospective study. Six patients' medical records were not found. Some documentation of the required information was weak and lacked complete data for 6 patients are potential confounding factors for this study. We advocate a more detailed prospective study regarding this matter in the future by obtaining more profound evidence. This would provide an evidencebased result and guidance in the management of patients with SHPT. More factors should be included in any future study to reduce the confounder effect. For example, preoperative urea level, serum vitamin D level and weight of parathyroid glands. Postoperative serum PTH should also be taken to exclude evidence of persistent disease after surgery. Postoperative serum PTH levels may further clarify the cause of hypocalcemia.
In conclusion, most of the patients with renal hyperpara thyroidism were symptomatic preoperatively and the most common clinical presentations were bone pain and muscle weakness. The significant predictor of early postoperative hypocalcemia after total parathyroidectomy in renal failure patients with SHPT was the preoperative alkaline phosphatase levels. Patients with high preoperative alkaline phosphatase should be monitored more closely in the early postoperative period.
